Herborium Expands Its HUT Group Partnership to Reach [Pounds]500,000 ($785,000.00) Sales in Europe.

About this update from Herborium Group, Inc.

[{"type":"text","content":"\nFort Lee, NJ, Dec. 11, 2014 (GLOBE NEWSWIRE) --  Herborium® Group,\nInc. (OTC Pink: HBRM),\n www.Herborium.com, a\nBotanical Therapeutics® Company and the provider of unique\nall  botanical medicines (Botanical Therapeutics®)\n announced today that HUT Group, LLC. , the UK's leading\nmulti-website online retailer of Health and Beauty products is\nexpending the marketing and sales of AcnEase®, Herborium's unique\nacne treatment  on its leading platforms with a goal of\n £500,000.00 ($785,000.00) in sales within  next 18-24\nmonths. Hut will also introduce Herborium' women, men and energy\nproducts in the European market in 2015.The Hut Group is one of Europe's fastest growing online\nlifestyle and health & and beauty destinations.  It is\ncurrently the UK's leading multi-website online retailer with\nrapidly growing global operations including a significant growth in\nAsia. Hut supports more than 140 million global website visitors, 5\nmillion customers and 8 million orders dispatched worldwide across\nsuch on line stores as www.myprotein.com, www.LookFantastic.com,\nwww.beautyexpert.co.uk,\nmankind.co.uk, www.coggles.com and others.\"We are very excited about the expansion of marketing and sales\nof AcnEase® and introduction of other Herborium products on Hut\nunique end to end technology platform. With potential for a million\npageviews daily our Botanical Therapeutics® will reach millions of\ncustomers in Europe and Asia.  We are expecting Hut's goal for\n£500 thousand in sales of AcnEase®  to be just a beginning of\nnew growth opportunities\" commented Dr. Agnes P. Olszewski, CEO and\nChairwoman of Herborium. About Herborium Group, Inc.Herborium Group, Inc., a botanical therapeutics® company that\ndevelops, license and markets proprietary, botanical based\nmedicinal products to consumers and healthcare professionals. The\nCompany business model focuses on emerging market opportunities\nspearheaded by the growth of a new market sector located between\nhigh-cost, high-risk, ethical pharmaceuticals and commoditized\nclassic nutraceuticals (supplements).  The Company uses\nclinical validation and a proactive regulatory strategy based on\nthe FDA Guidance for Industry: Botanical Drug Products\n(FDA Guidance 2004...

More updates from Herborium Group, Inc.